Structural and Functional Analyses of Trypanosoma brucei Nucleoside Diphosphate Kinase
Authors:
Open Access
- 9 March 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (11) , 17663-17677
Abstract
Trypanosoma brucei, the causative agent of Human African Trypanosomiasis (HAT), relies exclusively on purine salvage for nucleotide biosynthesis, making its nucleotide-processing enzymes attractive drug targets. Here, we present a comprehensive structural and functional characterization of T. brucei’s nucleoside diphosphate kinase B (TbNDPK), a key enzyme in nucleotide homeostasis. Circular dichroism and fluorescence spectroscopy revealed that TbNDPK is highly stable under thermal and chemical stress and undergoes nucleotide-induced conformational changes. This study also presents high-resolution crystal structures of the apo enzyme and complexes with UDP, CDP, and GDP, showing a conserved hexameric fold, with induced-fit binding via a flexible loop involving Phe59 and key active-site residues. Enzymatic assays revealed substrate preferences for UDP and GDP, while deoxyribonucleotide diphosphates were processed with significantly reduced efficiency. Molecular dynamics simulations revealed ligand-dependent flexibility and subunit-specific nucleotide dynamics, indicating potential asymmetry and cooperative communication within the hexamer. Collectively, these findings position TbNDPK as a thermostable, catalytically efficient, and structurally distinct enzyme optimized for ribonucleotide metabolism and support its potential as a selective target for future antitrypanosomal drug discovery.Keywords
Funding Information
- Division of Microbiology and Infectious Diseases (75N93022C00036)
This publication has 40 references indexed in Scilit:
- The comprehensive epidemiological status of human African trypanosomiasis in Nigeria: meta-analysis and systematic review of the full story (1962–2022)Parasitology Research, 2024
- Advancement in the development of DNA vaccines against Trypanosoma brucei and future perspectiveInternational Immunopharmacology, 2024
- Human African Trypanosomiasis (Sleeping Sickness)—Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and PreventionCurrent Tropical Medicine Reports, 2023
- Identifying inhibitors of Trypanosoma cruzi nucleoside diphosphate kinase 1 as potential repurposed drugs for Chagas’ diseaseBiochemical Pharmacology, 2023
- Characterisation of a unique linker segment of the Plasmodium falciparum cytosol localised Hsp110 chaperoneInternational Journal of Biological Macromolecules, 2021
- Diverse roles of nucleoside diphosphate kinase in genome stability and growth fitnessCurrent Genetics, 2020
- Protozoan Parasite Auxotrophies and Metabolic Dependencies2018
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- Pyrrole-indolinone SU11652 targets the nucleoside diphosphate kinase from Leishmania parasitesBiochemical and Biophysical Research Communications, 2017
- X-ray structure ofMycobacterium tuberculosis nucleoside diphosphate kinaseProteins: Structure, Function, and Bioinformatics, 2002